The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on January 28, 2020 at the USPTO Headquarters in Alexandria, VA. The agenda for the meeting is as follows:
• Welcoming and Opening Remarks (10:30 - 10:40 am ET) -- Gary Jones and Andrew Wang, Directors, and Karl Skowronek, Director (Acting), TC1600, USPTO
• Restriction practice (10:40 - 11:20 am) -- Janet Andres, SPE, TC1600, USPTO
• Orange Book and biologic patent study 11:20 - 12:00 pm) -- Michelle Ankenbrand, Lead Administrative Patent Judge, and Jason Repko, Administrative Patent Judge, PTAB, USPTO
• Lunch/Networking (12:00 - 1:00 pm)
• Patent term adjustment (1:00 - 1:50 pm) -- Kery Fries, Senior Legal Advisor, OPLA, USPTO
• Satisfying the written description requirement for living inventions (1:50 - 2:50 pm) -- Bethany Reid Roahrig, Patent Agent, Setter Roche LLP
• Break (2:50 - 3:00 pm)
• Subject matter eligibility (101) update (3:00 – 4:30 pm) – Zachariah Lucas, QAS, TC1600, USPTO
• Closing Remarks (4:30 - 4:40 pm) – Directors, TC1600, USPTO
Additional information regarding the BCP customer partnership meeting, including registration information for those wishing to attend the meeting or register for online participation, can be found here.
Comments